U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C31H30FN5O4
Molecular Weight 555.5994
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DANUGLIPRON

SMILES

OC(=O)C1=CC=C2N=C(CN3CCC(CC3)C4=NC(OCC5=CC=C(C=C5F)C#N)=CC=C4)N(C[C@@H]6CCO6)C2=C1

InChI

InChIKey=HYBAKUMPISVZQP-DEOSSOPVSA-N
InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1

HIDE SMILES / InChI

Molecular Formula C31H30FN5O4
Molecular Weight 555.5994
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Cmax

ValueDoseCo-administeredAnalytePopulation
136 ng/mL
40 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
245.3 ng/mL
80 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
415.8 ng/mL
120 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
2424 ng × h/mL
40 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
4691 ng × h/mL
80 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
6953 ng × h/mL
120 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
6.373 h
40 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
5.543 h
80 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
5.3 h
120 mg 2 times / day steady-state, oral
DANUGLIPRON plasma
Homo sapiens
Substance Class Chemical
Record UNII
DN9IUI24GP
Record Status Validated (UNII)
Record Version